Are you more of a visual learner? Check out our online video lectures and start your pharmacology course now for free!

anopheles stephensi

Image: “Anopheles stephensi.” by Jim Gathany – This media comes from the Centers for Disease Control and Prevention’s Public Health Image Library (PHIL), with identification number #5814. License: Public Domain

Overview of Malaria


Image: “Malarial sporozoites develop inside oocysts and are released in large numbers into the hemocoel of Anopheles stephensi mosquitoes.” by image by Ute Frevert; false color by Margaret Shear. License: CC BY 2.5

Malaria is caused by four different species of the protozoan parasite Plasmodium: P. falciparum, P. malariae, P. ovale, and P. vivax. These are transmitted by the bites of female Anopheles mosquitoes. Malaria caused by the P. falciparum species is severe; it can cause anemia and cerebral malaria. This parasite has a complex life cycle and is active in both the blood (erythrocytic schizonts) and the tissues, mainly the liver (exoerythrocytic forms of schizonts).

Treatment of malaria is aimed at killing the schizonts by one or more mechanisms. Resistance occurs when the parasite develops mechanisms that reduce the effects of the antimalarials or bypasses the mechanisms of the drug. Resistance is a major problem in some parts of the world, e.g., Africa and Southeast Asia; therefore, newer drugs are utilized. Monotherapy should be avoided to prevent drug resistance.

Malaria lifecycle CDC

Image: “A chart showing the lifecycle of the malaria parasite.” by Centers for Disease Control and Prevention (CDC). License: Public Domain

Classifications of Antimalarial Drugs

Chemical classification of antimalarials

4–Aminoquinoline derivatives: Chloroquine

4–Quinoline derivatives: Mefloquine

8–Aminoquinoline derivatives: Primaquine, Bulaquine

Cinchona alkaloid: Quinine, Quinidine

Biguanides: Proguanil

Diaminopyrimidines: Pyrimethamine

Sulfonamides and sulfones: Sulfadoxine, Dapsone

Sesquiterpene lactones: Artemisinin derivatives

Functional classification of antimalarials

Schizonticide: a drug that selectively kills schizonts of a sporozoan parasite (in this case, the malarial parasite).

  • Tissue schizonticides kill exoerythrocytic forms of schizonts, such as those in the liver (e.g., primaquine).
  • Blood schizonticides kill schizonts only in the erythrocyte (e.g., chloroquine, quinine).

Sporonticide: a drug that prevents sporogony and multiplication in the mosquito (e.g., proguanil, pyrimethamine).

Individual Antimalarial Drugs


This drug is rapidly and completely absorbed following oral administration. It concentrates in the erythrocytes, liver, spleen, kidney, lung, melanin-containing tissues, and leukocytes. Chloroquine also penetrates the central nervous system (CNS) and crosses the placenta.

Mechanism of Action

red blood cells infected with malaria

Image: “Electron micrograph of a Plasmodium falciparum-infected red blood cell (center), illustrating adhesion protein “knobs”.” by Rick Fairhurst and Jordan Zuspann. License: CC BY 2.0

Free heme is generated by the parasite while digesting the host cell’s hemoglobin. The parasite polymerizes the heme to hemozoin to avoid the toxic effects of the free heme; however, chloroquine accumulates in the food vacuoles of plasmodia and prevents polymerization of heme. Consequently, free heme causes the lysis of the parasite along with the red blood cells.

Note: Free heme is a cytotoxic agent. It causes damage to proteins, DNA, cell membranes, and cell organelles via oxidation and lipid peroxidation.

Clinical uses of Chloroquine

Chloroquine is the drug of choice for treatment and prophylaxis of all forms of malaria:

  • Non-resistant P. falciparum malaria prophylaxis and treatment
  • Vivax malaria treatment
  • Ovale malaria treatment

Adverse effects/toxicity

  • Gastrointestinal (GI) symptoms include nausea and vomiting.
  • Other symptoms include pruritus (mostly in the African population, lasting for 48–72 hours), headaches, blurred vision, and prolonged QT interval.
  • Severe adverse effects are rare.

Resistance: The parasite develops a membrane pump to flush out heme and transporter to flush out chloroquine. A mutation in the gene encoding for chloroquine resistance transporter protein (PfCRT) has a role in the development of resistance by Plasmodium.

Drug interactions

Antacids may decrease the oral absorption of chloroquine.


  • Presence of psoriasis and porphyria are contraindications for chloroquine.
  • Chloroquine should be avoided concomitantly with other drugs that prolong QT interval.


The mechanism of action of mefloquine is unknown. The drug has a long half-life (20 days).

Clinical uses

  • Resistant P. falciparum treatment
  • Falciparum malaria prophylaxis (once a week)

Adverse effects/toxicity

  • At high doses: nausea, vomiting, dizziness, disorientation, hallucinations, and depression
  • Prolonged QT interval and may precipitate torsade de pointes
  • Rare: pneumonitis

Drug interactions

  • Resistance to mefloquine confers cross-resistance to quinine and halofantrine.
  • ECG abnormalities and cardiac arrest can occur when taken with quinine or quinidine.


  • Neurologic and psychiatric disorders
  • Family history of seizures

Artemisinin derivatives

Artesunate, Artemether, and Arteether are artemisinin derivatives. These blood schizonticides are considered a superior antimalarial drug to quinine. Artemisinin clears the parasitic load in less time compared to other antimalarial drugs. It kills young parasites before they enter into the deep microvasculature.

To prevent the development of resistance, artemisinin derivatives should not be used as monotherapy. Possible combinations include artemether with lumefantrine; artesunate with mefloquine, clindamycin, etc.

The drugs have short half-lives; therefore, they cannot be used for prophylaxis. They are available as intravenous preparations.

Mechanism of action

  • Artemisinin derivatives accumulate in the protozoan’s food vacuoles and get metabolized to release toxic free radicals.
  • Additional possible action includes binding to and damaging certain parasite proteins.

Clinical uses

  • Artemether + lumefantrine: acute, uncomplicated malaria infections in adults and children > 5 kg
  • Multidrug-resistant P. falciparum treatment: They are the only drugs effective against quinine-resistant strains.
  • Severe malaria: Sometimes intravenous artesunate is used instead of quinine. This treatment is available for severe malaria in the United States and is the drug of choice in low-transmission areas and in the second and third trimesters of pregnancy.

Adverse effects/toxicity

  • Usually mild GI symptoms, such as nausea, vomiting, and diarrhea
  • Prolong QT interval
  • Hypersensitivity reactions and rash


This blood schizonticide is usually administered in combination with clindamycin, doxycycline, or tetracycline. It is available in oral and intravenous formulations.

Mechanism of action: As with chloroquine, quinine interferes with heme polymerization.

Clinical uses

  • Multidrug-resistant malaria treatment
  • Severe malaria, including cerebral malaria (intravenous quinine is the drug of choice.)
  • Quinidine, a stereoisomer of quinine, is the only non-oral drug approved by the United States Food and Drug Administration (U.S. FDA) for the treatment of severe malaria.
  • To avoid resistance development, quinine should not be given for prophylaxis.

Adverse effects/toxicity

  • Quinine is a cardiotoxic drug causing ventricular tachycardia, arrhythmia, hypotension, etc.
  • Prolonged QT interval and may precipitate torsade de pointes
  • Cinchonism: a syndrome of nausea, vomiting, tinnitus, and vertigo; however, this is reversible so therapy can continue.
  • Rarely hemolysis (blackwater fever), which can lead to hemolytic anemia, hemoglobinuria, and renal damage

Drug interactions

  • Enhances the activity of neuromuscular blockers
  • Increases digoxin levels
  • Absorption decreased with antacids containing aluminum hydroxide


  • Known hypersensitivity
  • Pregnancy


This tissue schizonticide and gametocide is the only agent that prevents the relapse of P. vivax and P. ovale malaria. It is not effective against blood schizonts.

Mechanism of action

Primaquine forms quinoline-quinone metabolites, which act as cellular oxidants. Its mechanism of action is not clearly understood; however, it is believed to damage the DNA structure and mitochondrial membranes of the parasite.

Clinical uses

  • Eradication of liver schizonts (liver hypnozoites)
  • Prophylaxis of P. vivax and P. ovale malaria

Adverse effects/toxicity

  • Usually well tolerated
  • GI distress symptoms, pruritus, headache, methemoglobinemia
  • Primaquine and its metabolites have oxidative activity and may be associated with methemoglobinemia, especially when the daily dose exceeds 60 mg


  • G6PD deficiency leads to hemolysis
  • Pregnancy

Antifolate Drugs

Proguanil, pyrimethamine, sulfadoxine, and dapsone are blood schizonticides. Pyrimethamine has a sporonticide action as well. Proguanil has a shorter half-life (12–16 hours) than others (> 100 hours).

Mechanism of action

  • Proguanil (a prodrug, biotransformed to cycloguanil) and pyrimethamine inhibit protozoan dihydrofolate reductases, which are needed for the synthesis of tetrahydrofolate, a cofactor that plays a role in the synthesis of nucleic acids.
  • Sulfonamides (sulfadoxine and dapsone) block folic acid synthesis by inhibiting dihydropteroate synthase.
  • Pyrimethamine and sulfadoxine (Fansidar) act by both of the above mechanisms, leading to a synergistic effect.

Clinical uses

  • Multidrug-resistant P. falciparum prophylaxis and treatment
  • Pyrimethamine and sulfadoxine (Fansidar): chloroquine-resistant P. falciparum treatment and toxoplasmosis treatment
  • Proguanil with atovaquone (Malarone): chloroquine- and mefloquine-resistant P. falciparum prophylaxis
  • Dapsone is used to treat leprosy in combination with trimethoprim. Like primaquine, it is also used to treat pneumocystis pneumonia.

Adverse effects/toxicity

  • Pyrimethamine may cause a folic acid deficiency in high doses, and megaloblastic anemia, which can be reversed with leucovorin.
  • Sulfonamides may cause skin rashes, GI symptoms, hemolysis, and kidney damage.

Drug Interactions: Carbamazepine increases doxycycline metabolism.


Doxycycline is a blood schizonticide.

Mechanism of action

Doxycycline inhibits protein synthesis in the bacteria by interfering with the binding of aminoacyl-tRNA molecules to bacterial ribosomes.

Clinical uses

  • P. falciparum malaria prophylaxis, including chloroquine-, mefloquine-, or multidrug-resistant malaria
  • P. falciparum malaria treatment in combination with quinine
  • Other clinical uses: gonorrhea, community-acquired pneumonia, Lyme disease, amebiasis, and others

Adverse effects/toxicity

  • Dizziness and vertigo, which are dose-dependent and reversible
  • Candidal vaginitis
  • Photosensitivity

Drug interactions

  • Carbamazepine and barbiturates increase doxycycline metabolism.
  • Phenytoin decreases doxycycline levels by stimulating its metabolism.

Contraindications: Younger children and pregnant women


This drug is similar to chloroquine but less metallic/bitter in taste and somewhat faster acting.

Mechanism of action: Similar to that of chloroquine

Clinical uses

  • Uncomplicated P. falciparum malaria treatment
  • Not used for prophylaxis

Adverse effects/toxicity

  • Similar to chloroquine
  • Neutropenia in pediatric patients

Drug interactions: Similar to chloroquine

Contraindications: Similar to chloroquine


Atovaquone is a rapidly acting blood schizonticide.

Mechanism of action

  • Inhibits mitochondrial electron transport by interrupting adenosine triphosphate (ATP) production and breaking down mitochondrial membranes
  • May also interfere with folate metabolism

Clinical uses

  • Mild to moderate pneumocystis pneumonia
  • Falciparum malaria prophylaxis and treatment in combination with proguanil (Malarone)
  • Also used for toxoplasmosis (including as a second-line drug in AIDS patients)

Adverse Effects/Toxicity: Coughing, rash, GI symptoms: nausea, vomiting, diarrhea

Contraindications: severe renal impairment

Halofantrine and Lumefantrine

Blood schizonticides

Halofantrine Lumefantrine
Mechanism of action Unknown
Clinical uses Not used anymore for malaria prophylaxis (effective against all 4 species) because of QT prolongation In combination with artemether: acute, uncomplicated malaria infections in adults and children > 5 kg
Adverse effects/toxicity GI symptoms: abdominal pain, diarrhea, vomiting; coughing, rash, headache, pruritus; prolongs QT interval and can precipitate Torsade de Pointes Extremely well tolerated, very mild GI symptoms, headache, etc. may rarely be seen.
Drug interactions Prior mefloquine therapy worsens QT interval prolongation
Contraindications Cardiac conduction defects

Drugs for Prophylaxis of Malaria in Travelers

Type of malaria Therapy
Chloroquine-sensitive P. falciparum Chloroquine or mefloquine (weekly)
Chloroquine-resistant P. falciparum Mefloquine (weekly)
Mefloquine – or multidrug-resistant malaria Doxycycline or Malarone (daily)
P. vivax and P. ovale Primaquine (daily for 14 days)

Antimalarial Drug Treatment in Severe Malaria

  • Intravenous (IV) quinidine (approved by the U.S. FDA)
  • IV quinine or IV artesunate (recommended by the World Health Organization, Centers for Disease Control and Prevention, and other sources)
  • After initial treatment with one of these drugs, a 1-week course of doxycycline is administered. If doxycycline is contraindicated, e.g., in the pediatric age group, clindamycin can be used.
Rate this article
1 Star2 Stars3 Stars4 Stars5 Stars (Votes: 3, average: 4.67)